IHLD MedTech has secured a strategic investment of $3 million from UltraGreen.ai, with a potential total commitment of $12 million, aimed at enhancing its AI-driven healthcare platforms.
This investment will support the expansion of IHLD MedTech’s two innovative platforms, iLiveConnect and WoundHeal+, which target chronic diseases and improve patient outcomes in India and beyond. iLiveConnect is designed for continuous patient care, providing real-time monitoring and support for chronic conditions, while WoundHeal+ utilizes advanced imaging and AI for effective wound management, addressing a critical need in India's healthcare landscape.
The partnership unites UltraGreen.ai’s expertise in fluorescence imaging and digital health with IHLD MedTech’s commitment to transforming care delivery. As the digital health market in India is poised for rapid growth, driven by AI integration and the need for remote monitoring, these platforms are well-positioned to meet emerging healthcare demands.
Both CEOs emphasized the significance of this collaboration, highlighting the potential to enhance patient engagement and outcomes through advanced technology and continuous clinical oversight. This investment marks a pivotal step for IHLD MedTech as it aims to scale its solutions effectively in a fast-evolving healthtech environment.